Skip to content

Author

Si Won Yang

We have 2 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Region-specific brain metabolite reference estimates and exploratory age-related changes in cognitively intact older adults: a preliminary deep-learning 1H-MRS study

Introduction Normative brain metabolite references are essential for evaluating metabolic change in rehabilitation patients with stroke, traumatic brain injury, or cognitive decline. We provide preliminary, cohort-specific reference estimates in cognitively healthy older adults using proton magnetic resonance spectroscopy (1H-MRS) and examine regional and age-related differences. Methods Twenty healthy older adults (10 males, 10 females; mean age 71.0 ± 9.5 years, range 56–84) underwent single-voxel 1H-MRS at 3T in three regions: dorsal anterior cingulate cortex (DACC), posterior cingulate cortex (PCC), and occipital cortex (OC). A Bayesian deep-learning convolutional neural network quantified 14 metabolite ratios normalized to total creatine (tCr). Because regions were acquired within each participant (20 independent observations), regional differences were evaluated primarily with the within-subject Friedman test (Kendall’s W), with Kruskal–Wallis as a secondary analysis; Benjamini–Hochberg false discovery rate (FDR) correction was applied across the 14 metabolites. Age– and MMSE–metabolite associations used Spearman’s rank correlation with FDR applied both across all 42 tests and within each region. Results Nine of 14 metabolites showed significant regional differences (seven also surviving the primary Friedman test after FDR correction), with glycerophosphocholine (GPC)/tCr showing the largest effect (Friedman W = 0.82; Kruskal–Wallis ε2 = 0.55). γ-aminobutyric acid (GABA)/tCr was highest in the OC, whereas myo-inositol (mI) and choline compounds were highest in the DACC. In exploratory age analyses, the PCC showed negative correlations for aspartate (Asp)/tCr (ρ = –0.61, p = 0.004) and glutathione (GSH)/tCr (ρ = –0.59, p = 0.006), both surviving region-wise FDR correction (q = 0.044), with glutamate (Glu)/tCr nominal (ρ = –0.45) and total N-acetylaspartate (tNAA)/tCr at trend level (ρ = –0.39); the DACC showed positive correlations for glucose (Glc)/tCr (ρ = +0.60) and lactate (Lac)/tCr (ρ = +0.50). No association survived the more conservative correction across all 42 tests. The OC showed no significant age associations. Conclusion This study established preliminary, cohort-specific multi-regional 1H-MRS reference estimates for cognitively intact older adults, with robust regional profiles and large effect sizes. The PCC showed exploratory age-related change—most consistently a coordinated aspartate–glutathione decline—requiring confirmation in larger cohorts, whereas the OC emerged as a candidate metabolically stable region.

Young-Ah Choi, Hyeong Hun Lee, D. Jang et al. · 0 citations
Aug 2026

Genetic Etiology and Neurodevelopmental Outcomes in Children With Craniosynostosis: A 15-Year Single-Center Retrospective Study.

BACKGROUND The traditional distinction between syndromic and nonsyndromic craniosynostosis has guided clinical management, but recent genomic advances suggest these categories represent a continuous spectrum rather than discrete entities. Data on genetic etiologies and long-term neurodevelopmental outcomes in Asian populations remain limited. METHODS The authors conducted a retrospective cohort study of 68 consecutive children diagnosed with craniosynostosis at a single tertiary center between January 2011 and November 2025. Genetic testing included whole-genome/whole-exome sequencing, targeted next-generation sequencing panels, and chromosomal microarray analysis (CMA). Neurodevelopmental assessments employed the Bayley Scales of Infant Development-III, Social Maturity Scale, Wechsler Intelligence Scales, and Beery-Buktenica Developmental Test of Visual-Motor Integration. Neurodevelopmental disorder (NDD) was defined as the presence of intellectual disability, autism spectrum disorder, or developmental language disorder; a secondary definition additionally included attention-deficit/hyperactivity disorder (ADHD). RESULTS Of 68 patients (40 males, 28 females), 39 (57.4%) underwent genetic testing, with pathogenic or likely pathogenic (P/LP) variants identified in 11 (28.2%; genetic-positive group). Identified variants involved chromatin modifiers (DNMT3A, NSD1, KMT2A), transcription factors (TCF12, SOX5), a signaling kinase (TAOK1), and a post-transcriptional regulator (TNRC6B); CMA additionally revealed pathogenic copy number variants (10q26.13-q26.3 deletion, 16p11.2 duplication, 15q11.2-q13.1 duplication, 2q37 deletion). In the primary analysis, NDD was identified in 8 of 11 patients (72.7%) in the genetic-positive group versus 10 of 28 (35.7%) in the genetic-negative group [P = 0.072; odds ratio (OR) 4.80, 95% confidence interval (CI) 1.03-22.29]. In the secondary analysis, including ADHD, NDD was significantly more prevalent in the genetic-positive group (9/11, 81.8% versus 11/28, 39.3%; P = 0.031; OR 6.95, 95% CI 1.26-38.44). CONCLUSIONS Comprehensive genetic testing yielded P/LP variants in 28.2% of tested craniosynostosis patients, revealing diverse molecular etiologies. Neurodevelopmental impairment was common and occurred even in genetically negative patients, supporting broad genetic evaluation together with systematic developmental surveillance for all affected children, independent of syndromic classification. LEVEL OF EVIDENCE Level III-Retrospective comparative study.

Sunyoung Joo, Jeon-Woong Kang, Si Won Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.